Clinical Trial Update: Fuzhenghuayu in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis [Phase 3]

View source ↗

Summary

This is an update on a Phase 3 trial evaluating Fuzhenghuayu in combination with ursodeoxycholic acid for primary biliary cholangitis. The status is listed as U…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangitis

Drugs mentioned

• Fuzhenghuayu (Fuzhenghuayu)
• Ursodeoxycholic acid (ursodeoxycholic acid)

Snippet

Sponsor: Xijing Hospital of Digestive Diseases | Conditions: Primary Biliary Cirrhosis | Phase 3 | Status: UNKNOWN